JS001
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for JS001, covering 2019-07-05 to 2025-08-28. Get the full timeline:
Most recent: Clinical Trial Update: JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC） [Phase 3]